Pagani FD - Search Results

1

Interhospital variability in health care-associated infections and payments after durable ventricular assist device implant among Medicare beneficiaries.

Likosky DS, Yang G, Zhang M, Malani PN, Fetters MD, Strobel RJ, Chenoweth CE, Hou H, Pagani FD; Michigan Congestive Heart Failure Investigators. Likosky DS, et al. Among authors: pagani fd. J Thorac Cardiovasc Surg. 2022 Nov;164(5):1561-1568. doi: 10.1016/j.jtcvs.2021.04.074. Epub 2021 May 4. J Thorac Cardiovasc Surg. 2022. PMID: 34099272 Free PMC article.

2

Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization.

Pagani FD, Lynch W, Swaniker F, Dyke DB, Bartlett R, Koelling T, Moscucci M, Deeb GM, Bolling S, Monaghan H, Aaronson KD. Pagani FD, et al. Circulation. 1999 Nov 9;100(19 Suppl):II206-10. doi: 10.1161/01.cir.100.suppl_2.ii-206. Circulation. 1999. PMID: 10567305

3

The impact of new technology on a clinical practice.

Sonnad SS, Bach DS, Bolling SF, Armstrong WF, Pagani FD, Shea MJ, Monaghan HM, Deeb GM. Sonnad SS, et al. Among authors: pagani fd. Semin Thorac Cardiovasc Surg. 1999 Oct;11(4 Suppl 1):79-82. Semin Thorac Cardiovasc Surg. 1999. PMID: 10660171

4

Assessment of an extracorporeal life support to LVAD bridge to heart transplant strategy.

Pagani FD, Aaronson KD, Dyke DB, Wright S, Swaniker F, Bartlett RH. Pagani FD, et al. Ann Thorac Surg. 2000 Dec;70(6):1977-84; discussion 1984-5. doi: 10.1016/s0003-4975(00)01998-6. Ann Thorac Surg. 2000. PMID: 11156106

5

LVAD therapy improves utilization of donor hearts: implications for prolonged inotropic therapy.

Aaronson K, Eppinger M, Wright S, Pagani FD. Aaronson K, et al. Among authors: pagani fd. J Heart Lung Transplant. 2001 Feb;20(2):241. doi: 10.1016/s1053-2498(00)00544-1. J Heart Lung Transplant. 2001. PMID: 11250471 No abstract available.

6

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device.

Pagani FD, Aaronson KD, Swaniker F, Bartlett RH. Pagani FD, et al. Ann Thorac Surg. 2001 Mar;71(3 Suppl):S77-81; discussion S82-5. doi: 10.1016/s0003-4975(00)02620-5. Ann Thorac Surg. 2001. PMID: 11265871

7

Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

Pagani FD, Dyke DB, Wright S, Cody R, Aaronson KD. Pagani FD, et al. J Heart Lung Transplant. 2001 Jun;20(6):646-53. doi: 10.1016/s1053-2498(01)00232-7. J Heart Lung Transplant. 2001. PMID: 11404170

8

Safety and efficacy of atorvastatin in heart transplant recipients.

Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD. Patel DN, et al. Among authors: pagani fd. J Heart Lung Transplant. 2002 Feb;21(2):204-10. doi: 10.1016/s1053-2498(01)00369-2. J Heart Lung Transplant. 2002. PMID: 11834348

9

Left ventricular assist device therapy improves utilization of donor hearts.

Aaronson KD, Eppinger MJ, Dyke DB, Wright S, Pagani FD. Aaronson KD, et al. Among authors: pagani fd. J Am Coll Cardiol. 2002 Apr 17;39(8):1247-54. doi: 10.1016/s0735-1097(02)01751-5. J Am Coll Cardiol. 2002. PMID: 11955839 Free article.

10

Nosocomial infections in left ventricular assist device recipients.

Malani PN, Dyke DB, Pagani FD, Chenoweth CE. Malani PN, et al. Among authors: pagani fd. Clin Infect Dis. 2002 May 15;34(10):1295-300. doi: 10.1086/340052. Epub 2002 Apr 22. Clin Infect Dis. 2002. PMID: 11981723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page